Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
"Research in Dr Kruse's lab aims to elucidate the molecular basis of transmembrane signaling through the use of biochemistry, pharmacological studies, and structural biology. He is particularly interested in signaling pathways with connections to human health and disease, including G protein-coupled receptors and other transmembrane receptors. In the long term, he aims to leverage a detailed molecular understanding of these pathways to facilitate the development of new and better therapeutics."
Plus d'informations : https://kruse.hms.harvard.edu/home
Evergrande Center for Immunologic Diseases, Harvard Medical School
contact: nathalie.bonnefoy@inserm.fr

CNIO, Madrid
Contact : Antonio Maraver

Instituto Madrileño de Estudios Avanzados, Madrid, Espagne
contact: antonio.maraver@inserm.fr
More detailshttps://www.food.imdea.org/metabolic-syndrome-group

Instituto Madrileño de Estudios Avanzados, Madrid, Espagne
contact: antonio.maraver@inserm.fr
More detailshttps://www.food.imdea.org/metabolic-syndrome-group

Santiago de Compostela University Hospital, Espagne
Contact IRCM : Antonio MARAVER
More detailshttps://stemchus.wordpress.com/lab-members/

Santiago de Compostela University Hospital, Espagne
Contact IRCM : Antonio MARAVER
More detailshttps://stemchus.wordpress.com/lab-members/

Syntego Inc
This seminar dedicated to researchers at the IRCM will cover the following topics:
• CRISPR Experimental Design and Optimization (Knock-outs and Knock-ins)
• Synthego robust loss of function screens for confident target discovery
• Using CRISPR to uncover protein functions and pathway analysis
Join us for an interactive session about the latest CRISPR advances and applications. Discover the impact of CRISPR in cancer and genetic disease research.